BioAsia 2025- Event Highlights - Healthark

The Healthark team actively participated in BioAsia 2025, engaging in insightful discussions, launching key reports, and connecting with industry leaders. Here are some #highlights from our time at the conference!

Sudeep Krishna, Co-Founder and President at Healthark moderated a GCC Roundtable: Navigating Challenges & Strategic Advantages where Shri Shakthi M Nagappan emphasized the growing role of #GCCs in India's life sciences landscape.

The session featured insights from Mrinal Duggal (Sanofi Hyderabad Hub), Mahesh Natarajan (Thermo Fisher Scientific), Shrinivas A. (Thryve Digital Health LLP), and Dr. Purav Gandhi (Healthark).

Discussions covered #scaling strategies, talent challenges, niche skill development, and outsourcing models. With India's LSHC GCCs projected to exceed $100B by 2030, this ecosystem is shaping the future of #healthcare innovation.
Download the LSHC GCC Outlook 2025: https://healthark.ai/report/expanding-horizons-the-maturity-journey-of-life-sciences-and-healthcare-gccs-in-india/

Healthark hosted The #GCC Networking Reception at BioAsia 2025- It was a fantastic platform to connect with biopharma pioneers and policymakers driving innovation in #lifesciences and #pharma.

A special thanks to Jayesh Ranjan Sir for addressing the gathering and setting the tone for an impactful evening.

We had the honor of launching our whitepaper: Expanding Horizons – The Maturity Journey of Life Sciences & Healthcare GCCs India’s Life Sciences & Healthcare GCCs are no longer just support hubs—they are driving global drug discovery, #clinical development, and digital transformation.

Some key highlights:
📍 85% of LSHC GCCs concentrated in four key cities
📍 A structured capability-based maturity framework
📍 The shift from cost efficiency to strategic value creation
🔗 Read the full report here: https://healthark.ai/report/expanding-horizons-the-maturity-journey-of-life-sciences-and-healthcare-gccs-in-india/

Dr. Purav Gandhi, CEO and Co founder at Healthark led a high-impact panel on Life Sciences GCCs: Shifting from Cost to Value!

The panel featured industry leaders:
John Dawber (Novo Nordisk)
Siva Kumar Padmanabhan (AstraZeneca India)
Mohit Dhingra (Bristol Myers Squibb)
Phani Mitra B (Dr. Reddy's Laboratories)
Puneet Chopra (Takeda)
Rajiv Onat (Regeneron)

Key themes: AI, advanced analytics, digital transformation, and ESG priorities redefining clinical research and global supply chains.

Healthark also launched its latest whitepaper, ‘Expanding Horizons – The Maturity Journey of Life Sciences & Healthcare GCCs in India’, unveiling how these centers are transforming drug discovery, clinical development, and digital innovation.

With 85% of LSHC #GCCs concentrated in four cities and a structured maturity framework, this report highlights the key enablers, challenges, and opportunities shaping their future.
Read the full report: https://healthark.ai/report/expanding-horizons-the-maturity-journey-of-life-sciences-and-healthcare-gccs-i

1. BioAsia 2025
Hyderabad
Event Highlights

2. Swipe to see the
Highlights!
Healthark played a key role, moderating & contributing to
discussions on healthcare innovation, biopharma, & digital
health, shaping the future of the industry.
70+
Speakers
50+
Countries
Participants
2800+ 1500+
Partnering
Meetings

3. SUDEEP
KRISHNA
Co-Founder & President
at Healthark, moderated a
panel on Global Capability
Centers (GCCs)
The session, featuring leaders from Sanofi,
Thryve Digital Health, Thermo Fisher Scientific
focused on scaling centers, talent challenges,
& the need for skilled workforces & effective
outsourcing strategies to drive growth
& innovation.

4. Healthark launched the
LSHC GCC Outlook 2025,
showcasing India’s growthin
Life Sciences & Healthcare
GCCs, projected to exceed
$100 billion by 2030.
Shri Jayesh Ranjan
Special Chief Secretary of Telangana’s IT &
Industries & Commerce Departments

5. Healthark hosted the Life Science
& Pharma GCC Networking
Reception, offering a great platform
to connect with biopharma pioneers
& policymakers, driving innovation
& strengthening collaboration in the
life sciences & pharmaceutical sectors.

7. Healthark unveiled the Expanding Horizons-The
Maturity Journey of Life Sciences and Healthcare
GCCs in India report, highlighting the shift of
GCCs from operational hubs to strategic drivers
of healthcare innovation.The report covered
India’s talent, digital ecosystem, and cost
advantages, along with challenges in talent
retention & regulatory complexities.

8. DR. PURAV
GANDHI
CEO & Co-founder
at Healthark led a
panel on Life
Sciences GCCs:
Shifting from
Cost to Value!

9. Leaders from
▪Novo Nordisk
▪AstraZeneca
▪Bristol Myers Squibb
▪Dr. Reddy's Laboratories
▪Takeda
▪Regeneron
Shared insights on the evolution of GCCs,
global teams, and Hyderabad's role in
innovation, focusing on talent,
infrastructure, and expansion
strategies
GANDHI

10. BioAsia 2025 showcased groundbreaking
discussions, meaningful collaborations, &
visionary insights. Healthark is proud to be at
the forefront of this transformation, shaping
the future of healthcare and life sciences.
Driving Impact,
Inspiring Innovation